Skip to main content

$20M Gift to Miami Institute for Human Genomics to Support Large-Scale Autism Sequencing Project


By Julia Karow

The University of Miami said last week that a $20 million gift to its medical school's Miami Institute for Human Genomics will contribute to a large-scale autism sequencing project.

"The application of next-generation genomic sequencing technology to the [institute's] extensive autism family dataset will give institute researchers data that will implicate genes responsible for autism risk and explain how those genes cause autism," said a statement from the university.

The $20 million gift to the institute comes from the John P. Hussman Foundation. Its founder, John Hussman, whose son was diagnosed with autism 12 years ago, is president and principal shareholder of Hussman Econometrics Advisors, an investment advisory firm that manages the Hussman Funds. Previously, he was a professor of economics and international finance at the University of Michigan.

The institute, which was founded two years ago and was recently renamed the John P. Hussman Institute for Human Genomics, had previously received an $80 million economic grant from the State of Florida, and funds from the new gift will go toward matching that grant. In addition, the institute has received support from the Dr. John T. Macdonald Foundation.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.